Discovery and optimisation of a selective non-steroidal glucocorticoid receptor antagonist
摘要:
High-throughput screening of 3.87 million compounds delivered a novel series of non-steroidal GR antagonists. Subsequent rounds of optimisation allowed progression from a non-selective ligand with a poor ADMET profile to an orally bioavailable, selective, stable, glucocorticoid receptor antagonist. (C) 2010 Published by Elsevier Ltd.
Discovery and optimisation of a selective non-steroidal glucocorticoid receptor antagonist
摘要:
High-throughput screening of 3.87 million compounds delivered a novel series of non-steroidal GR antagonists. Subsequent rounds of optimisation allowed progression from a non-selective ligand with a poor ADMET profile to an orally bioavailable, selective, stable, glucocorticoid receptor antagonist. (C) 2010 Published by Elsevier Ltd.